Ethics of prescribing drugs to enhance sporting performance

Medical Journal of Australia

Volumn 171, Issue 4, 1999, Pages 204-205

  Kennedy, Michael C ^a,b,c   Kennedy, Judith R ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b Dept Clin Pharmacol Toxicol ^*  (Australia)

^c Level 4   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANABOLIC AGENT; ANDROGEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIAMORPHINE; ERYTHROPOIETIN; GROWTH HORMONE; IMMUNOMODULATING AGENT; INSULIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROCHLORPERAZINE; PSEUDOEPHEDRINE; TAMOXIFEN; VITAMIN;

ACNE; ATHLETE; DOPING; DRUG USE; GYNECOMASTIA; HEART INFARCTION; HUMAN; MEDICAL ETHICS; MENTAL DISEASE; MUSCLE INJURY; PATIENT RIGHT; PHYSICAL PERFORMANCE; PRESCRIPTION; SHORT SURVEY; SPORT; STROKE;

EID: 0033575716     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1999.tb123600.x     Document Type: Short Survey

References (19)

1. Copeland J, Peters R, Dillon P. A study of 100 anabolic-androgenic steroid users [letter]. Med J Aust 1998; 168: 311-312.
2. Nilsson S. Androgenic anabolic steroid use among male adolescents in Falkenberg. Eur J Clin Pharmacol 1995; 48: 9-11.
3. Korkia P, Stimson GV. Indications of prevalence, practice and effects of anabolic steroid use in Great Britain, Int J Sports Med 1997; 18: 557-562.
4. Yesalis CE, Barsukiewicz CK, Kopstein AN, Bahrke MS. Trends in anabolic-androgenic steroid use among adolescents. Arch Pediatr Adolesc Med 1997; 151: 1197-1206.
5. Australian Sports Medicine Federation. Survey or drug use in Australian sport. Sports Coach 1988: 9-10.
6. Medical and nonmedical uses of anabolic-androgenic steroids. Council on Scientific Affairs. JAMA 1990; 264: 2923-2927.
7. Wu Z, Bidlingmaier M, Dall R, Strasburger CJ. Detection of doping with human growth hormone. Lancet 1999; 353: 895.
8. Sawka MN, Joyner MJ, Miles DS, et al. American College of Sports Medicine position stand. The use of blood doping as an ergogenic aid. Med Sci Sports Exerc 1996; 28: i-viii.
9. Willey J. Insulin as an anabolic aid? The Physician and Sports Medicine 1997; 25: 103-104.
10. Kennedy MC. Anabolic steroid abuse and toxicology. Aust N Z J Med 1992; 22: 374-381.
11. Corrigan B. Anabolic steroids and the mind. Med J Aust 1996; 165: 222-226.
12. Gillon R. Medical ethics: four principles plus attention to scope. BMJ 1994; 309: 184-188.
13. Laseter JT, Russell JA. Anabolic steroid-induced tendon pathology: a review of the literature. Med Sci Sports Exerc 1991; 23: 1-3.
14. Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 1996; 335: 1-7.
15. Kennedy MC, O'Sullivan AJ. Do anabolic-androgenic steroids enhance sporting performance? [editorial]. Med J Aust 1997; 116: 60-61.
16. Franke WW, Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem 1997; 43: 1262-1279.
17. Farrell M, Hall W. The Swiss heroin trials: testing alternative approaches [editorial]. BMJ 1998; 316: 639.
18. Fleming C. Abuse and trafficking in anabolic steroids - United States and Canada. A report to the Sir Winston Churchill Memorial Trust. Australia 1997.
19. Duda M. Do anabolic steroids pose an ethical dilemma for US physicians? Phys Sports Med 1986; 14: 173-175.